Glucuronosyltransferase

From WikiMD's WELLNESSPEDIA

Glucuronosyltransferase

Glucuronosyltransferase (also known as UDP-glucuronosyltransferase or UGT) is an important enzyme in the metabolism of various endogenous and exogenous compounds. It is primarily involved in the process of glucuronidation, a major phase II biotransformation reaction that enhances the solubility of lipophilic substances, facilitating their excretion from the body.

Function[edit]

Glucuronosyltransferase catalyzes the transfer of glucuronic acid from the cofactor uridine diphosphate glucuronic acid (UDPGA) to a variety of substrates, including bilirubin, hormones, drugs, and other xenobiotics. This reaction results in the formation of more water-soluble glucuronides, which can be readily excreted in the urine or bile.

Isoforms[edit]

There are multiple isoforms of glucuronosyltransferase, each encoded by different genes within the UGT gene family. These isoforms exhibit substrate specificity, meaning that different UGT enzymes are responsible for the glucuronidation of different substrates. The major UGT families include UGT1A and UGT2B.

Clinical Significance[edit]

Deficiencies or mutations in UGT enzymes can lead to various medical conditions. For example, mutations in the UGT1A1 gene can cause Gilbert's syndrome, a mild liver disorder characterized by intermittent jaundice. More severe mutations can result in Crigler-Najjar syndrome, a rare but serious condition that can lead to severe jaundice and neurological damage.

Regulation[edit]

The expression and activity of glucuronosyltransferase enzymes can be influenced by various factors, including genetic polymorphisms, diet, age, and the presence of other drugs or chemicals. Induction or inhibition of UGT enzymes can significantly affect the pharmacokinetics and toxicity of drugs.

Research and Applications[edit]

Research on glucuronosyltransferase is ongoing, with studies focusing on understanding its role in drug metabolism, the development of UGT inhibitors or inducers, and the implications of UGT polymorphisms in personalized medicine. The enzyme is also of interest in the field of toxicology for its role in the detoxification of harmful substances.

See Also[edit]

References[edit]


External Links[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.